{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T21:00:29Z","timestamp":1785013229242,"version":"3.55.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41366-026-02124-0","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:34:08Z","timestamp":1781012048000},"page":"1415-1425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual amylin and calcitonin receptor agonists as multifaceted disease-modifying osteoarthritis drugs"],"prefix":"10.1038","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3629-5421","authenticated-orcid":false,"given":"Khaled Elhady","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3286-4319","authenticated-orcid":false,"given":"Anna Thors\u00f8","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-1417","authenticated-orcid":false,"given":"Christian S.","family":"Thudium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2579-8437","authenticated-orcid":false,"given":"Andrea","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5026-8740","authenticated-orcid":false,"given":"Morten Asser","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-9297","authenticated-orcid":false,"given":"Anne-Christine","family":"Bay-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2770-0093","authenticated-orcid":false,"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"2124_CR1","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/art.42089","volume":"74","author":"H Long","year":"2022","unstructured":"Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, et al. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019. Arthritis Rheumatol. 2022;74:1172\u201383.","journal-title":"Arthritis Rheumatol"},{"key":"2124_CR2","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393:1745\u201359.","journal-title":"Lancet"},{"key":"2124_CR3","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/art.39707","volume":"68","author":"C Reyes","year":"2016","unstructured":"Reyes C, Leyland KM, Peat G, Cooper C, Arden NK, Prieto-Alhambra D. Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: a population-based cohort study. Arthritis Rheumatol. 2016;68:1869\u201375.","journal-title":"Arthritis Rheumatol"},{"key":"2124_CR4","first-page":"66","volume":"24","author":"L Chen","year":"2020","unstructured":"Chen L, Zheng JJY, Li G, Yuan J, Ebert JR, Li H, et al. Pathogenesis and clinical management of obesity-related knee osteoarthritis: impact of mechanical loading. J Orthop Transl. 2020;24:66\u201375.","journal-title":"J Orthop Transl"},{"key":"2124_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.arth.2013.02.036","volume":"28","author":"SM Odum","year":"2013","unstructured":"Odum SM, Springer BD, Dennos AC, Fehring TK. National obesity trends in total knee arthroplasty. J Arthroplast. 2013;28:148\u201351.","journal-title":"J Arthroplast"},{"key":"2124_CR6","doi-asserted-by":"publisher","unstructured":"Stevens-Lapsley JE, Kohrt WM. Osteoarthritis in women: effects of estrogen, obesity and physical activity. Women\u2019s Health. 601\u201315. https:\/\/doi.org\/10.2217\/whe.10.38.","DOI":"10.2217\/whe.10.38"},{"key":"2124_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NH Phelps","year":"2024","unstructured":"Phelps NH, Singleton RK, Zhou B, Heap RA, Mishra A, Bennett JE, et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403:1027\u201350.","journal-title":"Lancet"},{"key":"2124_CR8","doi-asserted-by":"crossref","unstructured":"Panunzi S, Maltese S, De Gaetano A, Capristo E, Bornstein SR, Mingrone G. Comparative efficacy of different weight loss treatments on knee osteoarthritis: A network meta-analysis. Obesity Reviews [Internet]. John Wiley & Sons, Ltd [cited 2022 Jan 25]. p. e13230. Available from: https:\/\/onlinelibrary-wiley-com.ep.fjernadgang.kb.dk\/doi\/full\/10.1111\/obr.13230.","DOI":"10.1111\/obr.13230"},{"key":"2124_CR9","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","volume":"27","author":"RR Bannuru","year":"2019","unstructured":"Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27:1578\u201389.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR10","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.22504","volume":"67","author":"R Christensen","year":"2015","unstructured":"Christensen R, Henriksen M, Leeds AR, Gudbergsen H, Christensen P, S\u00f8rensen TJ, et al. Effect of weight maintenance on symptoms of knee osteoarthritis in obese patients: a twelve-month randomized controlled trial. Arthritis Care Res (Hoboken). 2015;67:640\u201350.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2124_CR11","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.soard.2021.01.008","volume":"17","author":"Y Yu","year":"2021","unstructured":"Yu Y, Kalarchian MA, Ma Q, Groth SW. Eating patterns and unhealthy weight control behaviors are associated with loss of control eating following bariatric surgery. Surg Obes Relat Dis. 2021;17:976 .","journal-title":"Surg Obes Relat Dis"},{"key":"2124_CR12","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/NEJMoa2403664","volume":"391","author":"H Bliddal","year":"2024","unstructured":"Bliddal H, Bays H, Czernichow S, Udd\u00e9n Hemmingsson J, Hjelmes\u00e6th J, Hoffmann Morville T, et al. Once-weekly semaglutide in persons with obesity and knee osteoarthritis. N Engl J Med. 2024;391:1573\u201383.","journal-title":"N Engl J Med"},{"key":"2124_CR13","doi-asserted-by":"publisher","first-page":"156057","DOI":"10.1016\/j.metabol.2024.156057","volume":"161","author":"K Stefanakis","year":"2024","unstructured":"Stefanakis K, Kokkorakis M, Mantzoros CS. The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation. Metabolism. 2024;161:156057 .","journal-title":"Metabolism"},{"key":"2124_CR14","doi-asserted-by":"publisher","unstructured":"Hansen MS, W\u00f6lfel EM, Jeromdesella S, M\u00f8ller JJK, Ejersted C, J\u00f8rgensen NR, et al. Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial. EClinicalMedicine. 2024;72. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102624.","DOI":"10.1016\/j.eclinm.2024.102624"},{"key":"2124_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41572-025-00594-6","volume":"11","author":"S Tang","year":"2025","unstructured":"Tang S, Zhang C, Oo WM, Fu K, Risberg MA, Bierma-Zeinstra SM, et al. Osteoarthritis. Nat Rev Dis Prim. 2025;11:10 Dec 1SUBJMETA\u2009=\u20091669,1670,4023,407,692;KWRD\u2009=\u2009MUSCULOSKELETAL\u2009+\u2009ABNORMALITIES,OSTEOARTHRITI.","journal-title":"Nat Rev Dis Prim"},{"key":"2124_CR16","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/ard.2006.063354","volume":"66","author":"S Suri","year":"2007","unstructured":"Suri S, Gill SE, Massena de Camin S, McWilliams DF, Wilson D, Walsh DA. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis. 2007;66:1423\u20138.","journal-title":"Ann Rheum Dis"},{"key":"2124_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","volume":"101","author":"NB Finnerup","year":"2021","unstructured":"Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: from mechanisms to treatment. Physiol Rev. 2021;101:259\u2013301.","journal-title":"Physiol Rev"},{"key":"2124_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-12-134","volume":"12","author":"S Orita","year":"2011","unstructured":"Orita S, Ishikawa T, Miyagi M, Ochiai N, Inoue G, Eguchi Y, et al. Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet Disord. 2011;12:134.","journal-title":"BMC Musculoskelet Disord"},{"key":"2124_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2024-225928","volume":"84","author":"H Peters","year":"2025","unstructured":"Peters H, Potla P, Rockel JS, Tockovska T, Pastrello C, Jurisica I, et al. Cell and transcriptomic diversity of infrapatellar fat pad during knee osteoarthritis. Ann Rheum Dis. 2025;84:351\u201367.","journal-title":"Ann Rheum Dis"},{"key":"2124_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41584-020-00533-7","volume":"17","author":"PR Coryell","year":"2021","unstructured":"Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2021;17:47\u201357. SUBJMETA\u2009=\u20091354,1671,4023,631,692,80,86;KWRD\u2009=\u2009CARTILAGE,CELL\u2009+\u2009SIGNALLING.","journal-title":"Nat Rev Rheumatol"},{"key":"2124_CR21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.joca.2025.12.023","volume":"34","author":"FL Collins","year":"2026","unstructured":"Collins FL, Knights AJ, Maerz T, Roelofs AJ, De Bari C. Synovial fibroblast responses to different types of injury resulting in cartilage repair or osteoarthritis. Osteoarthr Cartil. 2026;34:384\u201394.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.joca.2021.06.013","volume":"30","author":"A Batushansky","year":"2022","unstructured":"Batushansky A, Zhu S, Komaravolu RK, South S, Mehta-D\u2019souza P, Griffin TM. Fundamentals of OA. An initiative of osteoarthritis and cartilage. obesity and metabolic factors in OA. Osteoarthr Cartil. 2022;30:501\u201315.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/ard.2008.106930","volume":"69","author":"E Yusuf","year":"2010","unstructured":"Yusuf E, Nelissen RG, Ioan-Facsinay A, Stojanovic-Susulic V, DeGroot J, Van Osch G, et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis. 2010;69:761\u20135.","journal-title":"Ann Rheum Dis"},{"key":"2124_CR24","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/jor.23459","volume":"35","author":"N Reina","year":"2017","unstructured":"Reina N, Cavaignac E, Pailh\u00e9 R, Pailliser A, Bonnevialle N, Swider P, et al. BMI-related microstructural changes in the tibial subchondral trabecular bone of patients with knee osteoarthritis. J Orthop Res. 2017;35:1653\u201360.","journal-title":"J Orthop Res"},{"key":"2124_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/annrheumdis-2020-218089","volume":"80","author":"W Hu","year":"2021","unstructured":"Hu W, Chen Y, Dou C, Dong S. Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Ann Rheum Dis. 2021;80:413\u201322.","journal-title":"Ann Rheum Dis"},{"key":"2124_CR26","doi-asserted-by":"publisher","unstructured":"Collins K. H., Lenz K. L., Pollitt E. N., Ferguson D., Hutson I., Springer L. E., et al. Adipose tissue is a critical regulator of osteoarthritis. Proc Natl Acad Sci USA. 118. https:\/\/doi.org\/10.1073\/pnas.2021096118.","DOI":"10.1073\/pnas.2021096118"},{"key":"2124_CR27","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/jor.23103","volume":"34","author":"KH Collins","year":"2016","unstructured":"Collins KH, Hart DA, Reimer RA, Seerattan RA, Herzog W. Response to diet-induced obesity produces time-dependent induction and progression of metabolic osteoarthritis in rat knees. J Orthop Res. 2016;34:1010\u20138.","journal-title":"J Orthop Res"},{"key":"2124_CR28","doi-asserted-by":"publisher","unstructured":"Binvignat M, Sellam J, Berenbaum F, Felson DT. The role of obesity and adipose tissue dysfunction in osteoarthritis pain. Nat Rev Rheumatol. 2024 https:\/\/doi.org\/10.1038\/s41584-024-01143-3.","DOI":"10.1038\/s41584-024-01143-3"},{"key":"2124_CR29","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/ard.2010.140046","volume":"70","author":"IR Klein-Wieringa","year":"2011","unstructured":"Klein-Wieringa IR, Kloppenburg M, Bastiaansen-Jenniskens YM, Yusuf E, Kwekkeboom JC, El-Bannoudi H, et al. The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann Rheum Dis. 2011;70:851\u20137.","journal-title":"Ann Rheum Dis"},{"key":"2124_CR30","doi-asserted-by":"publisher","first-page":"1598S","DOI":"10.1177\/1947603520980161","volume":"13","author":"SSJ Pragasam","year":"2021","unstructured":"Pragasam SSJ, Venkatesan V. Metabolic syndrome predisposes to osteoarthritis: lessons from model system. Cartilage. 2021;13:1598S\u20131609S.","journal-title":"Cartilage"},{"key":"2124_CR31","volume":"56","author":"B Zhang","year":"2026","unstructured":"Zhang B, Wang H, Qi W, Li S, Tao L, Peng X, et al. Plasma-derived exosomes from obese knee osteoarthritis aggravate synovitis by promoting cellular senescence of synovial fibroblasts. Solomon CG, editor J Orthop Transl. 2026;56:101031.","journal-title":"Solomon CG, editor J Orthop Transl"},{"key":"2124_CR32","doi-asserted-by":"crossref","unstructured":"Arden N. K., Perry T. A., Bannuru R. R., Bruy\u00e8re O., Cooper C., Haugen I. K. et al. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat Rev Rheumatol. 2020 17:1. 2020;17:59\u201366.","DOI":"10.1038\/s41584-020-00523-9"},{"key":"2124_CR33","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/s12276-021-00710-y","volume":"53","author":"Y Cho","year":"2021","unstructured":"Cho Y, Jeong S, Kim H, Kang D, Lee J, Kang SB, et al. Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions. Exp Mol Med. 2021;53:1689\u201396.","journal-title":"Exp Mol Med"},{"key":"2124_CR34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41584-020-00518-6","volume":"16","author":"A Latourte","year":"2020","unstructured":"Latourte A, Kloppenburg M, Richette P. Emerging pharmaceutical therapies for osteoarthritis. Nat Rev Rheumatol. 2020;16:673\u201388.","journal-title":"Nat Rev Rheumatol"},{"key":"2124_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2019.8044","volume":"322","author":"TJ Schnitzer","year":"2019","unstructured":"Schnitzer TJ, Easton R, Pang S, Levinson DJ, Pixton G, Viktrup L, et al. Effect of tanezumab on joint pain, physical function, and patient global assessment of osteoarthritis among patients with osteoarthritis of the hip or knee: a randomized clinical trial. JAMA - J Am Med Assoc. 2019;322:37\u201348.","journal-title":"JAMA - J Am Med Assoc"},{"key":"2124_CR36","doi-asserted-by":"crossref","unstructured":"DiMartino SJ, Gao H, Eng S, Valenzuela G, Fuerst T, Emeremni C, et al. Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hip. BMC Musculoskeletal Disorders 2025 26:1. 2025 Feb 25;26(1):192-..","DOI":"10.1186\/s12891-025-08402-8"},{"key":"2124_CR37","unstructured":"Fda, Cder, Mccrayk. Osteoarthritis: structural endpoints for the development of drugs, devices, and biological products for treatment guidance for industry DRAFT GUIDANCE [Internet] 2018. Report. Available from: https:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm."},{"key":"2124_CR38","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/art.20256","volume":"5","author":"SP Messier","year":"2004","unstructured":"Messier SP, Loeser RF, Miller GD, Morgan TM, Rejeski WJ. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: The arthritis, diet, and activity promotion trial. Arthritis Rheum. 2004;5:1501\u201310.","journal-title":"Arthritis Rheum"},{"key":"2124_CR39","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jama.2013.277669","volume":"310","author":"SP Messier","year":"2013","unstructured":"Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, DeVita P, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013;310:1263\u201373.","journal-title":"JAMA"},{"key":"2124_CR40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000449407","volume":"203","author":"AL Pogacnik Murillo","year":"2017","unstructured":"Pogacnik Murillo AL, Eckstein F, Wirth W, Beavers D, Loeser RF, Nicklas BJ, et al. Impact of diet and\/or exercise intervention on infrapatellar fat pad morphology: secondary analysis from the intensive diet and exercise for arthritis (IDEA) trial. Cells Tissues Organs. 2017;203:258\u201366.","journal-title":"Cells Tissues Organs"},{"key":"2124_CR41","doi-asserted-by":"crossref","unstructured":"Welhaven H. D., Welfley A. H., Bothner B., Messier S. P., Loeser R. F., June R. K. The metabolome of male and female individuals with knee osteoarthritis is influenced by 18-months of weight loss intervention: the IDEA trial. BMC Musculoskeletal Disorders 2024 25:1. 2024;25:1057.","DOI":"10.1186\/s12891-024-08166-7"},{"key":"2124_CR42","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1001\/jama.2016.3010","volume":"315","author":"WC King","year":"2016","unstructured":"King WC, Chen JY, Belle SH, Courcoulas AP, Dakin GF, Elder KA, et al. Change in pain and physical function following bariatric surgery for severe obesity. JAMA - J Am Med Assoc. 2016;315:1362\u201371.","journal-title":"JAMA - J Am Med Assoc"},{"key":"2124_CR43","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s11695-015-1845-x","volume":"26","author":"I Birn","year":"2015","unstructured":"Birn I, Mechlenburg I, Liljens\u00f8e A, Soballe K, Larsen JF. The association between preoperative symptoms of obesity in knee and hip joints and the change in quality of life after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2015;26:950\u20136.","journal-title":"Obes Surg"},{"key":"2124_CR44","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/ajcn\/nqaa328","volume":"113","author":"H Gudbergsen","year":"2021","unstructured":"Gudbergsen H, Overgaard A, Henriksen M, W\u00e6hrens EE, Bliddal H, Christensen R, et al. Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial. Am J Clin Nutr. 2021;113:314\u201323.","journal-title":"Am J Clin Nutr"},{"key":"2124_CR45","doi-asserted-by":"publisher","unstructured":"Qin H, Yu J, Yu H, Zhou C, Yuan D, Wang Z, et al. Semaglutide ameliorates osteoarthritis progression through a weight loss-independent metabolic restoration mechanism. Cell Metab. 2026. https:\/\/doi.org\/10.1016\/j.cmet.2026.01.008.","DOI":"10.1016\/j.cmet.2026.01.008"},{"key":"2124_CR46","unstructured":"Lilly\u2019s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial | Eli Lilly and Company [Internet]. [cited 2026 Jan 7]. Available from: https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-triple-agonist-retatrutide-delivered-weight-loss-average"},{"key":"2124_CR47","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.arth.2024.06.008","volume":"39","author":"MS Lavu","year":"2024","unstructured":"Lavu MS, Porto JR, Hecht CJ, Kaelber DC, Sculco PK, Heckmann ND, et al. The five-year incidence of progression to osteoarthritis and total joint arthroplasty in patients prescribed glucagon-like peptide 1 receptor agonists. J Arthroplast. 2024;39:2433\u20132439.e1.","journal-title":"J Arthroplast"},{"key":"2124_CR48","doi-asserted-by":"publisher","unstructured":"Liu S, Chen J, Du J, Song J, Kang Y, Zhang D, et al. Impact of metformin on the risk of osteoarthritis in patients with type 2 diabetes: a real-world study. Diabetes Res Clin Pract. 2026;113191. https:\/\/doi.org\/10.1016\/j.diabres.2026.113191.","DOI":"10.1016\/j.diabres.2026.113191"},{"key":"2124_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152908","volume":"77","author":"CL Kao","year":"2026","unstructured":"Kao CL, Chen SM, Hsieh CC, Peng TR, Tsai PY, Lin CY, et al. The efficacy of metformin for pain, function, and quality of life in knee osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2026;77:152908.","journal-title":"Semin Arthritis Rheum"},{"key":"2124_CR50","doi-asserted-by":"publisher","first-page":"S499","DOI":"10.1016\/j.joca.2024.02.743","volume":"32","author":"AC Bay-Jensen","year":"2024","unstructured":"Bay-Jensen AC, Muhamed K, Bihlet AR, Thudium CS, Henriksen K, Karsdal M. Weight loss lead to significant effects on OA pain and function: do the benefits outweigh the risks?. Osteoarthr Cartil. 2024;32:S499\u2013500.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR51","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.joca.2014.02.007","volume":"22","author":"AM Valdes","year":"2014","unstructured":"Valdes AM, Meulenbelt I, Chassaing E, Arden NK, Bierma-Zeinstra S, Hart D, et al. Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis. Osteoarthr Cartil. 2014;22:683\u20139.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/annrheumdis-2016-209252","volume":"76","author":"VB Kraus","year":"2017","unstructured":"Kraus VB, Collins JE, Hargrove D, Losina E, Nevitt M, Katz JN, et al. Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium. Ann Rheum Dis. 2017;76:186\u201395.","journal-title":"Ann Rheum Dis"},{"key":"2124_CR53","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.semarthrit.2020.03.002","volume":"50","author":"AR Bihlet","year":"2020","unstructured":"Bihlet AR, Bjerre-Bastos JJ, Andersen JR, Byrjalsen I, Karsdal MA, Bay-Jensen AC. Clinical and biochemical factors associated with risk of total joint replacement and radiographic progression in osteoarthritis: Data from two phase III clinical trials. Semin Arthritis Rheum. 2020;50:1374\u201381.","journal-title":"Semin Arthritis Rheum"},{"key":"2124_CR54","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.joca.2019.02.046","volume":"27","author":"JJ Bjerre-Bastos","year":"2019","unstructured":"Bjerre-Bastos JJ, Bay-Jensen AC, Karsdal MA, Byrjalsen I, Andersen JR, Riis BJ, et al. Biomarkers of bone and cartilage turnover CTX-I and CTX-II predict total joint replacements in osteoarthritis. Osteoarthr Cartil. 2019;27:S31\u20132.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101109","volume":"46","author":"N Sonne","year":"2021","unstructured":"Sonne N, Karsdal MA, Henriksen K. Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases. Mol Metab. 2021;46:101109.","journal-title":"Mol Metab"},{"key":"2124_CR56","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/art.21139","volume":"52","author":"SP Messier","year":"2005","unstructured":"Messier SP, Gutekunst DJ, Davis C, DeVita P. Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis. Arthritis Rheum. 2005;52:2026\u201332.","journal-title":"Arthritis Rheum"},{"key":"2124_CR57","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.2174\/1381612033453622","volume":"9","author":"N Mehta","year":"2005","unstructured":"Mehta N, Malootian A, Gilligan J. Calcitonin for osteoporosis and bone pain. Curr Pharm Des. 2005;9:2659\u201376.","journal-title":"Curr Pharm Des"},{"key":"2124_CR58","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1152\/physrev.00066.2017","volume":"99","author":"D Naot","year":"2019","unstructured":"Naot D, Musson DS, Cornish J. The activity of peptides of the calcitonin family in bone. Physiol Rev. 2019;99:781\u2013805.","journal-title":"Physiol Rev"},{"key":"2124_CR59","doi-asserted-by":"publisher","unstructured":"Bartelt A, Jeschke A, M\u00fcller B, Gaziano I, Morales M, Yorgan T, et al. Differential effects of Calca-derived peptides in male mice with diet-induced obesity. PLoS One. 2017;12. https:\/\/doi.org\/10.1371\/journal.pone.0180547.","DOI":"10.1371\/journal.pone.0180547"},{"key":"2124_CR60","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev. 2011;91:795\u2013826.","journal-title":"Physiol Rev"},{"key":"2124_CR61","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1210\/endo.142.11.8593","volume":"142","author":"PA Rushing","year":"2001","unstructured":"Rushing PA, Hagan MM, Seeley RJ, Lutz TA, D\u2019Alessio DA, Air EL, et al. Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology. 2001;142:5035\u20138.","journal-title":"Endocrinology"},{"key":"2124_CR62","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.2337\/db19-0849","volume":"69","author":"B Coester","year":"2020","unstructured":"Coester B, Koester-Hegmann C, Lutz TA, Foll C, Le. Amylin\/calcitonin receptor\u2013mediated signaling in pomc neurons influences energy balance and locomotor activity in chow-fed male mice. Diabetes. 2020;69:1110\u201325.","journal-title":"Diabetes"},{"key":"2124_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2020.170366","volume":"132","author":"L Boccia","year":"2020","unstructured":"Boccia L, Gamakharia S, Coester B, Whiting L, Lutz TA, Le Foll C. Amylin brain circuitry. Pept (NY). 2020;132:170366.","journal-title":"Pept (NY)"},{"key":"2124_CR64","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2174\/1389203720666190328111833","volume":"20","author":"W Ling","year":"2019","unstructured":"Ling W, Huang YM, Qiao YC, Zhang XX, Zhao HL. Human amylin: from pathology to physiology and pharmacology. Curr Protein Pept Sci. 2019;20:944\u201357.","journal-title":"Curr Protein Pept Sci"},{"key":"2124_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.14075","volume":"175","author":"DL Hay","year":"2018","unstructured":"Hay DL, Garelja ML, Poyner DR, Walker CS. Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR Review 25. Br J Pharm. 2018;175:3\u201317.","journal-title":"Br J Pharm"},{"key":"2124_CR66","doi-asserted-by":"publisher","first-page":"E598","DOI":"10.1152\/ajpendo.00419.2016","volume":"313","author":"S Gydesen","year":"2017","unstructured":"Gydesen S, Andreassen KV, Hjuler ST, Hellgren LI, Karsdal MA, Henriksen K. Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog. Am J Physiol Endocrinol Metab. 2017;313:E598\u2013607.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2124_CR67","doi-asserted-by":"publisher","unstructured":"Andreassen KV, Hjuler ST, Furness SG, Sexton PM, Christopoulos A, Nosjean O, et al. Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias. PLoS One. 2014;9. https:\/\/doi.org\/10.1371\/journal.pone.0092042.","DOI":"10.1371\/journal.pone.0092042"},{"key":"2124_CR68","doi-asserted-by":"publisher","unstructured":"Walker CS, Aitken JF, Vazhoor Amarsingh G, Zhang S, Cooper GJS. Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus. Nat Rev Endocrinol. 2025;482\u201394. https:\/\/doi.org\/10.1038\/s41574-025-01125-9.","DOI":"10.1038\/s41574-025-01125-9"},{"key":"2124_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113842","volume":"156","author":"AT Larsen","year":"2022","unstructured":"Larsen AT, Mohamed KE, Sonne N, Bredtoft E, Andersen F, Karsdal M, et al. Does receptor balance matter? \u2013 Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models. Biomed Pharmacother. 2022;156:113842.","journal-title":"Biomed Pharmacother"},{"key":"2124_CR70","first-page":"A389","volume":"52","author":"C Mack","year":"2003","unstructured":"Mack C, Hoyt J, Moore C, Jodka C, Sams-Dodd F. Sustained reduction in food intake and body weight in high-fat-fed rats during 28-day amylin infusion. Diabetes. 2003;52:A389\u2013A389.","journal-title":"Diabetes"},{"key":"2124_CR71","doi-asserted-by":"publisher","unstructured":"Larsen AT, Melander SA, Sonne N, Bredtoft E, Al-Rubai M, Karsdal MA, et al. Dual amylin and calcitonin receptor agonist treatment improves insulin sensitivity and increases muscle-specific glucose uptake independent of weight loss. Biomed Pharmacotherapy 2023;164. https:\/\/doi.org\/10.1016\/j.biopha.2023.114969.","DOI":"10.1016\/j.biopha.2023.114969"},{"key":"2124_CR72","doi-asserted-by":"publisher","unstructured":"Bradley D. The intriguing intersection of type 2 diabetes, obesity-related insulin resistance, and osteoarthritis. J Clin Endocrinol Metab Endocrine Soc. 2021;E2370\u20132. https:\/\/doi.org\/10.1210\/clinem\/dgab009.","DOI":"10.1210\/clinem\/dgab009"},{"key":"2124_CR73","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejphar.2015.05.051","volume":"762","author":"ST Hjuler","year":"2015","unstructured":"Hjuler ST, Andreassen KV, Gydesen S, Karsdal MA, Henriksen K. KBP-042 improves bodyweight and glucose homeostasis with indices of increased insulin sensitivity irrespective of route of administration. Eur J Pharm. 2015;762:229\u201338.","journal-title":"Eur J Pharm"},{"key":"2124_CR74","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1126\/sciadv.adt5915","volume":"11","author":"KH Collins","year":"2025","unstructured":"Collins KH, Lenz KL, Welhaven HD, Ely E, Springer LE, Paradi S, et al. Adipose-derived leptin and complement factor D mediate osteoarthritis severity and pain. Sci Adv. 2025;11:5915 .","journal-title":"Sci Adv"},{"key":"2124_CR75","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","volume":"18","author":"E Sanchez-Lopez","year":"2022","unstructured":"Sanchez-Lopez E, Coras R, Torres A, Lane NE, Guma M. Synovial inflammation in osteoarthritis progression. Nat Rev Rheumatol. 2022;18:258\u201375.","journal-title":"Nat Rev Rheumatol"},{"key":"2124_CR76","first-page":"1","volume":"6736","author":"JP Frias","year":"2023","unstructured":"Frias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, et al. Efficacy and safety of co-administered once-weekly cagrilintide 2\u00b74\u2009mg with once-weekly semaglutide 2\u00b74\u2009mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. Lancet. 2023;6736:1\u201311.","journal-title":"Lancet"},{"key":"2124_CR77","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00774-016-0765-8","volume":"35","author":"N Endo","year":"2017","unstructured":"Endo N, Fujino K, Doi T, Akai M, Hoshino Y, Nakano T, et al. Effect of elcatonin versus nonsteroidal anti-inflammatory medications for acute back pain in patients with osteoporotic vertebral fracture: a multiclinic randomized controlled trial. J Bone Min Metab. 2017;35:375\u201384.","journal-title":"J Bone Min Metab"},{"key":"2124_CR78","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1007\/s00198-016-3652-1","volume":"27","author":"CB Yeh","year":"2016","unstructured":"Yeh CB, Weng SJ, Chang KW, Chan JYH, Huang SM, Chu TH, et al. Calcitonin alleviates hyperalgesia in osteoporotic rats by modulating serotonin transporter activity. Osteoporos Int. 2016;27:3355\u201364.","journal-title":"Osteoporos Int"},{"key":"2124_CR79","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1523\/JNEUROSCI.20-16-06302.2000","volume":"20","author":"A Ito","year":"2000","unstructured":"Ito A, Kumamoto E, Takeda M, Takeda M, Shibata K, Sagai H, et al. Mechanisms for ovariectomy-induced hyperalgesia and its relief by calcitonin: participation of 5-HT1A-like receptor on C-afferent terminals in substantia gelatinosa of the rat spinal cord. J Neurosci. 2000;20:6302\u20138.","journal-title":"J Neurosci"},{"key":"2124_CR80","doi-asserted-by":"publisher","unstructured":"Wen ZH, Tang CC, Chang YC, Huang SY, Lin YY, Hsieh SP, et al. Calcitonin attenuates cartilage degeneration and nociception in an experimental rat model of osteoarthritis: Role of TGF-\u03b2 in chondrocytes. Sci Rep. 2016;6. https:\/\/doi.org\/10.1038\/srep28862.","DOI":"10.1038\/srep28862"},{"key":"2124_CR81","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.joca.2019.05.016","volume":"27","author":"A Katri","year":"2019","unstructured":"Katri A, D\u0105browska A, L\u00f6fvall H, Karsdal MA, Andreassen KV, Thudium CS, et al. A dual amylin and calcitonin receptor agonist inhibits pain behavior and reduces cartilage pathology in an osteoarthritis rat model. Osteoarthr Cartil. 2019;27:1339\u201346.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR82","doi-asserted-by":"publisher","unstructured":"Mohamed KE, Larsen AT, Melander S, Andersen F, Kerrn EB, Karsdal MA, et al. The dual amylin and calcitonin receptor agonist KBP-336 elicits a unique combination of weight loss, antinociception and bone protection\u2014a novel disease-modifying osteoarthritis drug. Arthritis Res Ther. 2024;26. https:\/\/doi.org\/10.1186\/s13075-024-03361-2.","DOI":"10.1186\/s13075-024-03361-2"},{"key":"2124_CR83","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3346\/jkms.2012.27.11.1405","volume":"27","author":"O Armagan","year":"2012","unstructured":"Armagan O, Serin DK, Calisir C, Dokumacioglu A, Ozgen M, Oner S, et al. Inhalation therapy of calcitonin relieves osteoarthritis of the Knee. J Korean Med Sci. 2012;27:1405\u201310.","journal-title":"J Korean Med Sci"},{"key":"2124_CR84","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00296-012-2399-z","volume":"33","author":"M Esenyel","year":"2013","unstructured":"Esenyel M, \u0130\u00e7a\u011fas\u0131o\u011flu A, Esenyel CZ. Effects of calcitonin on knee osteoarthritis and quality of life. Rheumatol Int. 2013;33:423\u20137.","journal-title":"Rheumatol Int"},{"key":"2124_CR85","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.joca.2014.12.019","volume":"23","author":"MA Karsdal","year":"2015","unstructured":"Karsdal MA, Byrjalsen I, Alexandersen P, Bihlet A, Andersen JR, Riis BJ, et al. Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: Results from two phase 3 trials. Osteoarthr Cartil. 2015;23:532\u201343.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR86","doi-asserted-by":"crossref","unstructured":"Karsdal MA, Henriksen K, Arnold M, Christiansen C. Calcitonin - A drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality. BioDrugs. 2008:137\u201344.","DOI":"10.2165\/00063030-200822030-00001"},{"key":"2124_CR87","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.joca.2022.07.003","volume":"30","author":"K Aso","year":"2022","unstructured":"Aso K, Walsh DA, Wada H, Izumi M, Tomitori H, Fujii K, et al. Time course and localization of nerve growth factor expression and sensory nerve growth during progression of knee osteoarthritis in rats. Osteoarthr Cartil. 2022;30:1344\u201355","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR88","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1515\/jbcpp-2017-0032","volume":"28","author":"WJ Adeyemi","year":"2017","unstructured":"Adeyemi WJ, Olayaki LA. Effects of single or combined administration of salmon calcitonin and omega-3 fatty acids vs. diclofenac sodium in sodium monoiodoacetate-induced knee osteoarthritis in male Wistar rats. J Basic Clin Physiol Pharm. 2017;28:573\u201382.","journal-title":"J Basic Clin Physiol Pharm"},{"key":"2124_CR89","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.joca.2011.11.004","volume":"20","author":"BC Sondergaard","year":"2012","unstructured":"Sondergaard BC, Catala-Lehnen P, Huebner AK, Bay-Jensen AC, Schinke T, Henriksen K, et al. Mice over-expressing salmon calcitonin have strongly attenuated osteoarthritic histopathological changes after destabilization of the medial meniscus. Osteoarthr Cartil. 2012;20:136\u201343.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR90","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.joca.2006.10.012","volume":"15","author":"NA Papaioannou","year":"2007","unstructured":"Papaioannou NA, Triantafillopoulos IK, Khaldi L, Krallis N, Galanos A, Lyritis GP. Effect of calcitonin in early and late stages of experimentally induced osteoarthritis. A histomorphometric study. Osteoarthr Cartil. 2007;15:386\u201395.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR91","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.joca.2013.03.011","volume":"21","author":"MJ Kyrkos","year":"2013","unstructured":"Kyrkos MJ, Papavasiliou KA, Kenanidis E, Tsiridis E, Sayegh FE, Kapetanos GA. Calcitonin delays the progress of early-stage mechanically induced osteoarthritis. Invivo, prospective study. Osteoarthr Cartil. 2013;21:973\u201380.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR92","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/03008207.2012.760549","volume":"54","author":"T Cheng","year":"2013","unstructured":"Cheng T, Zhang L, Fu X, Wang W, Xu H, Song H, et al. The potential protective effects of calcitonin involved in coordinating chondrocyte response, extracellular matrix, and subchondral trabecular bone in experimental osteoarthritis. Connect Tissue Res. 2013;54:139\u201346.","journal-title":"Connect Tissue Res"},{"key":"2124_CR93","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.joca.2011.01.008","volume":"19","author":"RH Nielsen","year":"2011","unstructured":"Nielsen RH, Bay-Jensen AC, Byrjalsen I, Karsdal MA. Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover. Osteoarthr Cartil. 2011;19:466\u201373.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR94","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/1529-0131(199906)42:6<1159::AID-ANR12>3.0.CO;2-Q","volume":"42","author":"DH Manicourt","year":"1999","unstructured":"Manicourt DH, Altman RD, Williams JM, Devogelaer JP, Van Egeren AD, Lenz ME, et al. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions. Arthritis Rheum. 1999;42:1159\u201367.","journal-title":"Arthritis Rheum"},{"key":"2124_CR95","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.joca.2004.08.005","volume":"12","author":"H El Hajjaji","year":"2004","unstructured":"El Hajjaji H, Williams JM, Devogelaer JP, Lenz ME, Thonar EJMA, Manicourt DH. Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis. Osteoarthr Cartil. 2004;12:904\u201311.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR96","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bone.2005.04.032","volume":"37","author":"YZ Bagger","year":"2005","unstructured":"Bagger YZ, Tank\u00f3 LB, Alexandersen P, Karsdal MA, Olson M, Mindeholm L, et al. Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis. Bone. 2005;37:425\u201330.","journal-title":"Bone"},{"key":"2124_CR97","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1124\/jpet.119.257576","volume":"370","author":"AT Larsen","year":"2019","unstructured":"Larsen AT, Sonne N, Andreassen KV, Gehring K, Karsdal MA, Henriksen K. The dual amylin and calcitonin receptor agonist KBP-088 induces weight loss and improves insulin sensitivity superior to chronic amylin therapy. J Pharm Exp Ther. 2019;370:35\u201343.","journal-title":"J Pharm Exp Ther"},{"key":"2124_CR98","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1001\/jama.2020.2938","volume":"323","author":"G Cai","year":"2020","unstructured":"Cai G, Aitken D, Laslett LL, Pelletier JP, Martel-Pelletier J, Hill C, et al. Effect of intravenous zoledronic acid on tibiofemoral cartilage volume among patients with knee osteoarthritis with bone marrow lesions. JAMA. 2020;323:1456 .","journal-title":"JAMA"},{"key":"2124_CR99","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.joca.2021.02.004","volume":"29","author":"Y Yazici","year":"2021","unstructured":"Yazici Y, McAlindon TE, Gibofsky A, Lane NE, Lattermann C, Skrepnik N, et al. A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2\/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis. Osteoarthr Cartil. 2021;29:654\u201366.","journal-title":"Osteoarthr Cartil"},{"key":"2124_CR100","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2019.14735","volume":"322","author":"MC Hochberg","year":"2019","unstructured":"Hochberg MC, Guermazi A, Guehring H, Aydemir A, Wax S, Fleuranceau-Morel P, et al. Effect of intra-articular sprifermin vs placebo on femorotibial joint cartilage thickness in patients with osteoarthritis: the FORWARD randomized clinical trial. JAMA - J Am Med Assoc. 2019;322:1360\u201370.","journal-title":"JAMA - J Am Med Assoc"},{"key":"2124_CR101","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/annrheumdis-2020-218547","volume":"80","author":"P Richette","year":"2021","unstructured":"Richette P, Latourte A, Sellam J, Wendling D, Piperno M, Goupille P, et al. Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial. Ann Rheum Dis. 2021;80:349\u201355.","journal-title":"Ann Rheum Dis"},{"key":"2124_CR102","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/0031-9384(95)02067-5","volume":"58","author":"TA Lutz","year":"1995","unstructured":"Lutz TA, Geary N, Szabady MM, Del Prete E, Scharrer E. Amylin decreases meal size in rats. Physiol Behav. 1995;58:1197\u2013202.","journal-title":"Physiol Behav"},{"key":"2124_CR103","first-page":"1654","volume":"271","author":"U Arnelo","year":"1996","unstructured":"Arnelo U, Permert J, Adrian TE, Larsson J, Reidelberger RD, Larsson J, et al. Chronic infusion of islet amyloid polypeptide causes anorexia in rats. Am J fo Physiol. 1996;271:1654\u20139.","journal-title":"Am J fo Physiol"},{"key":"2124_CR104","doi-asserted-by":"publisher","unstructured":"Kern K. A., Dibrog A. M., Przybysz J. T., Mietlicki-baase E. G. Effects of pramlintide on energy intake and food preference in rats given a choice diet. Physiol Behav. 2021;pre-proof:113541. https:\/\/doi.org\/10.1016\/j.physbeh.2021.113541.","DOI":"10.1016\/j.physbeh.2021.113541"},{"key":"2124_CR105","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/BF00401833","volume":"38","author":"AA Young","year":"1995","unstructured":"Young AA, Gedulin B, Vine W, Percy A, Rink TJ. Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia. 1995;38:642\u20138.","journal-title":"Diabetologia"},{"key":"2124_CR106","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1210\/en.2006-0393","volume":"147","author":"JD Roth","year":"2006","unstructured":"Roth JD, Hughes H, Kendall E, Baron AD, Anderson CM. Antiobesity effects of the \u03b2-cell hormone amylin in diet-induced obese rats: Effects on food intake, body weight, composition, energy expenditure, and gene expression. Endocrinology. 2006;147:5855\u201364.","journal-title":"Endocrinology"},{"key":"2124_CR107","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0167-0115(02)00252-5","volume":"111","author":"B \u00c5kesson","year":"2003","unstructured":"\u00c5kesson B, Panagiotidis G, Westermark P, Lundquist I. Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets. Regul Pept. 2003;111:55\u201360.","journal-title":"Regul Pept"},{"key":"2124_CR108","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejphar.2012.09.007","volume":"696","author":"M Aoki","year":"2012","unstructured":"Aoki M, Mori A, Nakahara T, Sakamoto K, Ishii K. Effect of synthetic eel calcitonin, elcatonin, on cold and mechanical allodynia induced by oxaliplatin and paclitaxel in rats. Eur J Pharm. 2012;696:62\u20139.","journal-title":"Eur J Pharm"},{"key":"2124_CR109","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S8756-3282(02)00701-9","volume":"30","author":"M Azria","year":"2002","unstructured":"Azria M. Possible mechanisms of the analgesic action of calcitonin. Bone. 2002;30:80\u20133.","journal-title":"Bone"},{"key":"2124_CR110","doi-asserted-by":"publisher","unstructured":"Karsdal M. A., Byrjalsen I., Riis B. J., Christiansen C. Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin. BMC Clin Pharmacol. 2008;8. https:\/\/doi.org\/10.1186\/1472-6904-8-12.","DOI":"10.1186\/1472-6904-8-12"},{"key":"2124_CR111","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00198-008-0603-5","volume":"19","author":"MA Karsdal","year":"2008","unstructured":"Karsdal MA, Byrjalsen I, Leeming DJ, Delmas PD, Christiansen C. The effects of oral calcitonin on bone collagen maturation: implications for bone turnover and quality. Osteoporos Int. 2008;19:1355\u201361.","journal-title":"Osteoporos Int"},{"key":"2124_CR112","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/145749691210100405","volume":"101","author":"IO Arnala","year":"2012","unstructured":"Arnala IO. Salmon calcitonin (Miacalcic NS 200 IU) in prevention of bone loss after hip replacement. Scand J Surg. 2012;101:249\u201354.","journal-title":"Scand J Surg"},{"key":"2124_CR113","doi-asserted-by":"publisher","unstructured":"Keller J., Catala-Lehnen P., Huebner A. K., Jeschke A., Heckt T., Lueth A., et al. Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts. Nat Commun. 2014;5. https:\/\/doi.org\/10.1038\/ncomms6215.","DOI":"10.1038\/ncomms6215"},{"key":"2124_CR114","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bone.2016.01.025","volume":"85","author":"M Tsukamoto","year":"2016","unstructured":"Tsukamoto M, Menuki K, Murai T, Hatakeyama A, Takada S, Furukawa K, et al. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells. Bone. 2016;85:70\u201380.","journal-title":"Bone"},{"key":"2124_CR115","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bone.2016.07.019","volume":"91","author":"K Henriksen","year":"2016","unstructured":"Henriksen K, Byrjalsen I, Andersen JR, Bihlet AR, Russo LA, Alexandersen P, et al. A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D. Bone. 2016;91:122\u20139.","journal-title":"Bone"},{"key":"2124_CR116","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bone.2019.02.019","volume":"122","author":"K Manglani","year":"2019","unstructured":"Manglani K, Vijayan V, Pathak C, Khandelwal M, Singh P, Chellappa S, et al. Development and characterization of supramolecular calcitonin assembly and assessment of its interactions with the bone remodelling process. Bone. 2019;122:123\u201335.","journal-title":"Bone"},{"key":"2124_CR117","doi-asserted-by":"publisher","first-page":"558392","DOI":"10.3389\/fendo.2020.00613","volume":"11","author":"CY Hsiao","year":"2020","unstructured":"Hsiao CY, Chen TH, Chu TH, Ting YN, Tsai PJ, Shyu JF. Calcitonin induces bone formation by increasing expression of Wnt10b in osteoclasts in ovariectomy-induced osteoporotic rats. Front Endocrinol (Lausanne). 2020;11:558392.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2124_CR118","doi-asserted-by":"publisher","unstructured":"Wu L, Cheng L, Yang J, Yan Y, Zhang E, Kochovski Z, et al. Construction of active protein materials: manipulation on morphology of salmon calcitonin assemblies with enhanced bone regeneration effect. Adv Mater. 2022;34. https:\/\/doi.org\/10.1002\/adma.202207526.","DOI":"10.1002\/adma.202207526"},{"key":"2124_CR119","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.62347\/ZMAL4724","volume":"16","author":"Z Rui","year":"2024","unstructured":"Rui Z, Yan C, Wang Z, Yuan Y, Luan C, Wang L. The effects of alfacalcidol combined with calcitonin in the treatment of osteoporosis and its influence on levels of inflammation. Am J Transl Res. 2024;16:1690\u2013700.","journal-title":"Am J Transl Res"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02124-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02124-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02124-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T20:02:00Z","timestamp":1785009720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02124-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":119,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2124"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02124-0","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KEM, ATL, CST, MAK, ACBJ, and KH are employed by Nordic Bioscience A\/S. MAK, KH, CST, and ACBJ own stock in Nordic Bioscience A\/S. AB has no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}